Clinical Trials
2 trialsNCT04777708 2023-03-24
BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
Jonsson Comprehensive Cancer Center
Phase EARLY_PHASE1 Terminated
NCT03099564 2023-02-06
Pembrolizumab Plus Y90 Radioembolization in HCC Subjects
Hoosier Cancer Research Network
Phase EARLY_PHASE1 Unknown